explainthisobservedvariationinexercise-inducedcog- ticipants for the training intervention and the instruc-
nitivebenefitsintermsofcostsandconsequences. torsfortheircommitmenttotheparticipants’healthand
safety.
JenniferC.Davis,MSc,PhD
CarloA.Marra,PharmD,PhD 1. TinettiME,SpeechleyM,GinterSF.Riskfactorsforfallsamongelderlyper-
B.LynnBeattie,MD sonslivinginthecommunity.NEnglJMed.1988;319(26):1701-1707.
2. vanDijkPT,MeulenbergOG,vandeSandeHJ,HabbemaJD.Fallsindemen-
M.ClareRobertson,PhD tiapatients.Gerontologist.1993;33(2):200-204.
MehdiNajafzadeh,MSc 3. Liu-AmbroseT,DonaldsonMG,AhamedY,etal.Otagohome-basedstrength
andbalanceretrainingimprovesexecutivefunctioninginolderfallers:aran-
PeterGraf,PhD domizedcontrolledtrial.JAmGeriatrSoc.2008;56(10):1821-1830.
LindsayS.Nagamatsu,MA 4. Liu-AmbroseT,NagamatsuLS,GrafP,BeattieBL,AsheMC,HandyTC.
Resistancetrainingandexecutivefunctions:a12-monthrandomizedcon-
TeresaLiu-Ambrose,PT,PhD
trolledtrial.ArchInternMed.2010;170(2):170-178.
5. ColcombeSJ,KramerAF,EricksonKI,etal.Cardiovascularfitness,cortical
AuthorAffiliations:TheCentreforHipHealthandMo- plasticity,andaging.ProcNatlAcadSciUSA.2004;101(9):3316-3321.
6. CassilhasRC,VianaVA,GrassmannV,etal.Theimpactofresistanceexer-
bility (Drs Davis and Liu-Ambrose) and The Brain Re- ciseonthecognitivefunctionoftheelderly.MedSciSportsExerc.2007;39
searchCentre(DrsBeattie,Graf,andLiu-Ambroseand (8):1401-1407.
7. DavisJC,MarraC,RobertsonMC,etal.Economicevaluationofdose-
MsNagamatsu),VancouverCoastalHealthResearchIn-
responseresistancetraininginolderwomen:acosteffectivenessandcostutil-
stitute,CollaborationforOutcomesResearchandEvalu- ityanalysis[publishedonlineAugust4,2010].OsteoporosInt. doi:10.1007
ation(CORE),FacultyofPharmaceuticalSciences(Drs /s00198-010-1356-5.
8. GrafP,UttlB,TuokkoH.Color-andpicture-wordStrooptests:performance
Davis and Marra and Mr Najafzadeh), Department of
changesinoldage.JClinExpNeuropsychol.1995;17(3):390-415.
PhysicalTherapy(DrLiu-Ambrose),DepartmentofPsy-
chology(DrGraf),andDivisionofGeriatricMedicine,
FacultyofMedicine(DrBeattie),UniversityofBritishCo-
lumbia,Vancouver,BritishColumbia,Canada;andOtago
HEALTH CARE REFORM
SchoolofMedicine,UniversityofOtago,Dunedin,New
Zealand(DrRobertson).
Correspondence:DrLiu-Ambrose,DepartmentofPhys-
Hospital-Based Palliative
iotherapy,UniversityofBritishColumbia,311-2647Wil-
low St, Vancouver, BC V5Z 3P1, Canada (tlambrose Medicine Consultation:
@exchange.ubc.ca). A Randomized Controlled Trial
AuthorContributions:Allauthorshadfullaccesstoall
H
ofthedata(includingstatisticalreportsandtables)inthe ospital-based palliative care consultation ser-
studyandtakeresponsibilityfortheintegrityofthedata vices increase patient and family satisfac-
andtheaccuracyofthedataanalysis.Studyconceptand tion,1,2 improve quality of life,3 reduce inten-
design:Marra,Beattie,Graf,andLiu-Ambrose.Acquisition sivecareunitlengthofstay,4anddecreasecosts.2,5Clear
ofdata:NagamatsuandLiu-Ambrose.Analysisandinter- evidenceoftheeffectivenessofpalliativecareconsulta-
pretationofdata:Marra,Beattie,Robertson,Najafzadeh, tionservicesinimprovingsymptomshasbeenmoreelu-
Nagamatsu,andLiu-Ambrose.Draftingofthemanuscript: sive.2,3,6Weconductedarandomizedtrialtoevaluatethe
Liu-Ambrose.Criticalrevisionofthemanuscriptforimpor- impact of a proactive palliative medicine consultation
tant intellectual content: Marra, Beattie, Robertson, Na- (PMC) on the care of chronically ill, hospitalized el-
jafzadeh,Graf,Nagamatsu,andLiu-Ambrose.Statistical derlypatients.
analysis:Marra,Najafzadeh,andLiu-Ambrose.Obtained
funding:Beattie,Graf,andLiu-Ambrose.Administrative,tech- Methods.Thestudysettingwasa560-bedacademicmedi-
nical,andmaterialsupport:NagamatsuandLiu-Ambrose. calcenter.Weincludedpatients65yearsorolderwith
Studysupervision:Marra,Robertson,andLiu-Ambrose. heartfailure,cancer,chronicobstructivepulmonarydis-
FinancialDisclosure:Nonereported. ease,orcirrhosis,whowereabletogiveinformedcon-
Funding/Support:TheVancouverFoundation(BCMSF, sentandwhospokeEnglish
operatinggranttoDrLiu-Ambrose)andtheMSFHR(es- Thisstudywasarandomized,prospective,clinicaltrial.
tablishmentgranttoDrLiu-Ambrose)providedfunding TheinterventiongroupreceivedaPMConenrollment
for this study. The Canada Foundation for Innovation andeveryweekdayduringhospitalization.Fourphysi-
fundedessentialinfrastructureusedinthisstudy(newop- cianssharedPMCduties.ThePMCphysiciansawinter-
portunitiesfundtoDrLiu-Ambrose). ventionpatientsdaily,routinelyassessedsymptomsand
Trial Registration: clinicaltrials.gov Identifier: psychosocialandspiritualneeds,discussedtreatmentpref-
NCT00426881 erences, and consulted a pharmacist and chaplain as
AdditionalInformation:DrsMarraandLiu-Ambroseare needed.ThePMCphysiciancommunicatedfindingsand
Michael Smith Foundation for Health Research Schol- recommendationstothepatient’steamviaamedicalchart
ars.DrMarraisaCanadaResearchChairinPharmaceu- noteandbytelephone.Theusualcaregroupreceiveda
tical Outcomes. Dr Davis is a Canadian Institutes for briefvisitfromthePMCphysicianwhogavethemapacket
Health Research Canada Graduate Scholarship PhD ofinformationondietandexercise.
trainee. Onadmission,weusedtheActivitiesofDailyLiving
AdditionalContributions:WethanktheVancouverSouth (ADL)7andInstrumentalActivitiesofDailyLiving(IADL)
Slope YMCA management and members who enthusi- scales8tocategorizeeachsubjectasdependentorinde-
asticallysupportedthestudybyallowingaccesstopar- pendent.Participantsreportingtheneedforassistance
(REPRINTED)ARCHINTERNMED/VOL170(NO.22), DEC13/27,2010 WWW.ARCHINTERNMED.COM
2038
©2010AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://archinte.jamanetwork.com/ by a University of Pittsburgh User on 05/02/2016
with any 1 of 13 tasks were categorized as dependent.
Weusedthe15-itemGeriatricDepressionScale(GDS-
15)toassessdepression.9Responseswerescored1=“no”
10
and“don’tknow”and0=“yes”andsummed.Totalscores
of 6 or higher indicated the patient may be depressed. 8
Pain,dyspnea,andanxietywereassesseddailybyare-
search assistant who was blinded to group assignment 6
andaskedpatientstorateeachsymptomatitsworstlevel
inthepast24hoursfrom0(“none”)to10(“theworst 4
youcanimagine”).Patientswererandomlyassignedto
theinterventionorusualcaregroup.Allpatientscom- 2
pletedatelephonesurvey2weeksafterdischargetore-
assesssymptoms,ratephysicianandnursingcare,and 0
recalldiscussionsofpreferences.Wereviewedmedical
recordstodeterminepatients’primarydiagnosisonad-
mission.ThisstudywasundertakenbetweenJanuary2002
andDecember2003andapprovedbytheUniversityof
California, San Francisco Committee on Human Re-
search.Allparticipantsgavewritteninformedconsent.
Frequencies,means,andstandarddeviationswereused
toexaminethedistributionofmeasures.Weused(cid:2)2analy-
sistotestforbivariateassociationsbetweencategorical
variables.Repeated-measuresanalysisofvariancewasused
to investigate the impact of the intervention on symp-
tomseverityoverdifferentassessmentperiods.Weused
theStatisticalPackagefortheSocialSciences(SPSS)for
Mac(version17;SPSSInc,Chicago,Illinois;March11,
2009).
Results.Weenrolled107patients(intervention,n=54;
usualcare,n=53);81patients(76%;intervention,n=41;
usualcare,n=40)completedfollow-upsurveys.Mostpa-
tientsweremale(62%)andwhite(71%)andhadsome
collegeeducation(56%).Themean(SD)agewas76(7.5)
years,and45%weremarriedorpartnered.Theprimary
diagnoses were heart failure (51%; mean ejection frac-
tion,23%);cancer(22%;type:prostate,22%;lung,18%;
andbladder,13%);chronicobstructivepulmonarydis-
ease(20%;meanforcedexpiratoryvolumein1second
of1.5L);andcirrhosis(6%;meanModelforEndstage
LiverDiseasescore,16).Themean(SD)hospitallength
of stay was 5.5 (5.8) days. Most participants were de-
pendantin1ormoreADL(71%),and21%hadaGDS-IS
scoreof6orhigher.Thegroupsdifferedinmeanage(77
and74yearsintheinterventionandusualcaregroups,
respectively;P=.007)butnotinothercharacteristics.
Symptomscoresforallsubjectsimprovedfrombase- Comment.Consistentwithpreviousresearch,ourPMC
linetofollow-upforpain(4.2vs2.3;P(cid:3).001),dyspnea
interventionwasnotbetterthanusualcareinreducing
(3.8vs2.0;P(cid:3).001),andanxiety(4.8vs2.4;P(cid:3).001).
the severity of symptoms among chronically ill inpa-
Therewasnoadditionalimprovementinpain(P=.30), tients.Inaddition,mostpatientsinbothgroupsratedtheir
dyspnea (P=.50), or anxiety (P=.08) for patients as- carehighly,whileonlyaminorityofpatients,eveninthe
signed to the intervention at any assessment period interventiongroup,reporteddiscussionsofpreferences
(Figure). orprognosiseventhoughsuchconversationswereacore
Atfollow-up,mostpatientsbelievedthatthestaffun- componentofourPMC.
derstoodwhattheyweregoingthroughandthatphysi- Anumberoffactorsmayhavecontributedtothesere-
ciansandnurseslistenedtotheirhopes,fears,andbe- sults. First, our subjects were not those otherwise re-
liefs(Table).However,aminorityofpatientsreported ferredforPMCandthusmayhavelackedissuesthata
that the physician discussed their preferences for care PMCwouldaffect.Wethoughtthatclinicianswouldre-
(43%),theirchanceofsurvivinghospitalization(42%), sistrandomizingpatientstheyreferredforPMCandthere-
or their religious beliefs (31%). There were no differ- forerecruitedinpatientsunlikelytobereferred.Despite
encesbetweengroupsforanyoftheseitems. consensusthatpatientsatanystageofillnessshouldre-
niaP
fo
leveL
A
Usual Care
PMC
F = 1.1
P = .30
3.5 (2.4-4.8) 3.3 (2.2-4.4)
2.1 (1.1-3.1)
10
8
6
4
2
0
aenpsyD
fo
leveL
B
F = 0.7
P = .50
3.0 (1.8-4.2)
1.8 (0.9-1.1) 1.6 (0.6-2.5)
10
8
6
4
2
0
Assessment Period
yteixnA
fo
leveL
4.9 (3.8-6.0)
3.5 (2.5-4.5)
2.4 (1.4-3.4)
4.4 (3.3-5.5)
3.5 (2.6-4.5)
2.4 (1.5-3.3)
C
F = 2.9
5.5 (4.2-5.5) P = .08
3.9 (2.8-4.9)
2.5 (1.5-3.6)
3.8 (2.7-5.0)
3.3 (2.2-4.4)
2.5 (1.3-3.6)
Baseline 24 Hours Follow-up
Figure.Worstpain(A),dyspnea(B),andanxiety(C)inthepast24hours.
Dataaregivenasmean(95%confidenceinterval).PMCindicatespalliative
medicineconsultation.
(REPRINTED)ARCHINTERNMED/VOL170(NO.22), DEC13/27,2010 WWW.ARCHINTERNMED.COM
2039
©2010AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://archinte.jamanetwork.com/ by a University of Pittsburgh User on 05/02/2016
Correspondence:DrPantilat,PalliativeCareProgram,
Table.PatientRatingsforFollow-upQuestionsRegarding University of California, San Francisco, 521 Parnassus
Care,Preferences,Prognosis,andSpiritualCareComparing
Ave,SteC-126,SanFrancisco,CA94143-0903(stevep
UsualCareandInterventionGroups
@medicine.ucsf.edu).
FinancialDisclosure:DrLandefeldhasreceivedgrants
Patients,No./Total(%)
P fromtheNationalInstituteonAging,theJohnA.Hart-
Question UsualCare Intervention Value fordFoundation,andtheS.D.BechtelJrFoundation.
Didadoctortellyouabout 19/40(48) 15/40(38) .50 Funding/Support:ThisstudywasfundedandDrPanti-
choicesfortreatment?(Yes) latsupportedbygrant1-K23-AG01018-01fromtheNa-
Didyouhavespecificwishes 8/40(20) 6/40(15) .80 tionalInstituteonAging.
orplansaboutthetypesof AdditionalContributions:Wethankallpatientsandfami-
medicaltreatmentthatyou
lieswhoparticipatedinthisstudyandthePMCphysi-
wanted?(Yes)
Didadoctortalkwithyou 13/40(33) 21/41(51) .11 cians,pharmacist,andchaplainwhohelpedcareforthem.
aboutthechancesthatyou JoanneBatt,BA,WrennLevenberg,BA,andEmilyPhil-
wouldsurvivethelast ipps,BA,researchassistantsforthePalliativeCarePro-
hospitalization?(Yes)
gramatUniversityofCalifornia,SanFrancisco(UCSF),
Didsomeoneonthehealth 9/39(23) 16/41(39) .15
contributedtothedevelopmentofresourcesandthecol-
careteamtalkwithyou
aboutyourreligiousbeliefs? lectionandmanagementofdata.StephenJ.McPhee,MD
(Yes) (UCSF), and Bernard Lo, MD (UCSF), provided input
Didsomeoneonthehealthcare 3/38(8) 5/40(13) .71 onthedesignofthestudy.
teamsuggestseeinga
religiousleader?(Yes) 1. DySM,ShugarmanLR,LorenzKA,MularskiRA,LynnJ;RAND-Southern
Didyoufeelthatanyoneatthe 33/38(87) 31/41(76) .26 CaliforniaEvidence-BasedPracticeCenter.Asystematicreviewofsatisfac-
hospitalreallyunderstood tionwithcareattheendoflife.JAmGeriatrSoc.2008;56(1):124-129.
whatyouandyourfamily 2. GadeG,VenohrI,ConnerD,etal.Impactofaninpatientpalliativecareteam:
weregoingthrough?(Yes) arandomizedcontroltrial.JPalliatMed.2008;11(2):180-190.
Didadoctorreallylistentoyou 17/21(81) 20/26(77) (cid:4).99 3. MorrisonRS.Healthcaresystemfactorsaffectingend-of-lifecare.JPalliat
Med.2005;8(suppl1):S79-S87.
aboutyourhopes,fears,and 4. BackAL,LiYF,SalesAE.Impactofpalliativecarecasemanagementonre-
beliefsasmuchasyou sourceusebypatientsdyingofcancerataVeteransAffairsmedicalcenter.
wanted?(Yes) JPalliatMed.2005;8(1):26-35.
Didthenursesreallylistento 16/18(89) 24/27(89) (cid:4).99 5. MorrisonRS,PenrodJD,CasselJB,etal;PalliativeCareLeadershipCen-
youaboutyourhopes,fears, ters’OutcomesGroup.CostsavingsassociatedwithUShospitalpalliative
careconsultationprograms.ArchInternMed.2008;168(16):1783-1790.
andbeliefsasmuchasyou
6. BakitasM,LyonsKD,HegelMT,etal.Effectsofapalliativecareinterven-
wanted?(Yes)
tiononclinicaloutcomesinpatientswithadvancedcancer:theProject
ENABLEIIrandomizedcontrolledtrial.JAMA.2009;302(7):741-749.
7. KatzS,FordAB,MoskowitzRW,JacksonBA,JaffeMW.Studiesofillness
ceivepalliativecare,atearlierstagespalliativecaremay intheaged:theindexofADL:astandardizedmeasureofbiologicalandpsy-
chosocialfunction.JAMA.1963;185:914-919.
haveanimpactondifferentoutcomesorrequireongo-
8. LawtonMP,BrodyEM.Assessmentofolderpeople:self-maintainingand
ingengagement.10Second,atrulyinterdisciplinaryteam, instrumentalactivitiesofdailyliving.Gerontologist.1969;9(3):179-186.
aswehavenow,mayhavehadanimpact,whereasthe 9. SchreinerAS,HayakawaH,MorimotoT,KakumaT.Screeningforlatelife
depression:cut-offscoresfortheGeriatricDepressionScaleandtheCor-
physician-focusedPMCdidnot. nellScaleforDepressioninDementiaamongJapanesesubjects.IntJGeriatr
The following limitations temper our results. Find- Psychiatry.2003;18(6):498-505.
10. RabowMW,DibbleSL,PantilatSZ,McPheeSJ.Thecomprehensivecareteam:
ingsfrom1institutionmaynotbegeneralizable,though
acontrolledtrialofoutpatientpalliativemedicineconsultation.ArchIntern
patientsenrolledhadcommonconditions.Althoughwe Med.2004;164(1):83-91.
relied on self-report measures, such reporting is stan-
dardandwouldnotaccountforlackofeffect.Priorde-
scriptiveandotherrigorousstudieshavedemonstrated COMMENTS AND OPINIONS
benefitsofPMC.Therefore,thelackofpositivefindings
in our randomized trial should not dissuade clinicians
from referring to a palliative care consultation service Medical Devices and the Approval
buthighlightstheneedforfurtherrigorouslydesigned Processes: United States vs France
research to demonstrate which approach to palliative
R
careprovidedtowhichpatientswouldimprovepatient edbergrightlysupportedtheplansforthenew
outcomes. approvalprocessfromtheUSFoodandDrugAd-
ministration (FDA) for medical devices.1 The
StevenZ.Pantilat,MD FDA has announced it will significantly strengthen its
DavidL.O’Riordan,PhD premarketclearanceprocess(whichisunderreviewby
SuzanneL.Dibble,DNSc,RN theInstituteofMedicine)andtheprocessfordevelop-
C.SethLandefeld,MD ingandreviewingpostmarketdata.1TheFDAalsohas
announcedanewtransparencyinitiativerequiringthat
AuthorAffiliations:PalliativeCareProgram(DrsPanti- clinicaldatabepubliclyavailable.Indeed,aprudentpolicy
lat and O’Riordan), Institute for Health and Aging (Dr iswarrantedbeforeapproval:high-qualityclinicaldata
Dibble),andDivisionofGeriatrics(DrLandefeld),Uni- mustshowthatthebenefitsoutweightherisks.
versityofCalifornia,SanFrancisco,andSanFrancisco, Sadly,theASTRAL(AngioplastyandStentforRenal
VAMedicalCenter(DrLandefeld). ArteryLesions)trialwillnotbethelastonetoremind
(REPRINTED)ARCHINTERNMED/VOL170(NO.22), DEC13/27,2010 WWW.ARCHINTERNMED.COM
2040
©2010AmericanMedicalAssociation.Allrightsreserved.
Downloaded From: http://archinte.jamanetwork.com/ by a University of Pittsburgh User on 05/02/2016
